Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 143,207 |
|
|||||
| News | - | ||||||
| Day High | 9.655 | Low High |
|||||
| Day Low | 9.175 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Fennec Pharmaceuticals Inc | FENC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.23 | -2.40% | 9.34 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.52 | 9.175 | 9.655 | 9.34 | 9.57 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,285 | 143,207 | $ 9.34 | $ 1,338,086 | - | 6.30 - 11.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:03:57 | 22 | $ 9.37 | USD |
Fennec Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 341.44M | 26.63M | - | 21.25M | -16.05M | -0.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Fennec Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FENC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.81 | 10.92 | 9.175 | 9.97 | 148,089 | -1.47 | -13.60% |
| 1 Month | 11.16 | 11.47 | 9.175 | 10.62 | 132,172 | -1.82 | -16.31% |
| 3 Months | 9.90 | 11.49 | 8.59 | 10.16 | 129,354 | -0.56 | -5.66% |
| 6 Months | 6.80 | 11.92 | 6.55 | 9.74 | 123,891 | 2.54 | 37.35% |
| 1 Year | 8.29 | 11.92 | 6.30 | 9.06 | 112,289 | 1.05 | 12.67% |
| 3 Years | 6.51 | 11.92 | 3.8219 | 7.91 | 101,226 | 2.83 | 43.47% |
| 5 Years | 4.66 | 11.92 | 3.255 | 7.46 | 115,830 | 4.68 | 100.43% |
Fennec Pharmaceuticals Description
| Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. |
